Radiofrequency ablation for single hepatocellular carcinoma 3 cm or less as first-line treatment

AIM: To evaluate long-term outcomes of radiofrequency (RF) ablation as first-line therapy for single hepatocellular carcinoma (HCC) ≤ 3 cm and to determine survival and prognostic factors. METHODS: We included all 184 patients who underwent RF ablation as a first-line treatment for single HCC ≤ 3 cm...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:World J Gastroenterol
Main Authors: Gao, Jun, Wang, Shao-Hong, Ding, Xue-Mei, Sun, Wen-Bing, Li, Xiao-Long, Xin, Zong-Hai, Ning, Chun-Min, Guo, Shi-Gang
Formato: Artigo
Idioma:Inglês
Publicado: Baishideng Publishing Group Inc 2015
Assuntos:
Retrospective Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4419069/
https://ncbi.nlm.nih.gov/pubmed/25954102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i17.5287
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares